|
|
||||||||
Journal of Lipid Research, Vol 38, 206-216, Copyright © 1997 by Lipid Research, Inc.
ARTICLES |
S Murthy, S Mathur, WP Bishop and EJ Field
Department of Internal Medicine, University of Iowa, Iowa City 52242, USA.
Small intestinal mucosal inflammation observed in celiac disease is associated with the local release of growth factors and various cytokines. In a previous study, we investigated the effect of various cytokines on triacylglycerol and apoB secretion by CaCo-2 cells and observed that TNF-alpha, IL-1 beta, and particularly IL-6, decreased apolipoprotein (apo) B and triacylglycerol secretion. In this study, we explored possible mechanisms to explain the inhibitory effect of IL-6 on apoB secretion. IL-6, 10 ng/mL, added to the basolateral medium of CaCo-2 cells grown on semi-permeable filters, decreased apoB secretion by 42%. Adding a blocking monoclonal antibody (mAb 528) to the EGF receptor completely prevented this effect. IL-6 decreased the amount of EGF receptor protein and the binding of iodinated EGF to its receptor by 50% and 30%, respectively. Incubation of cells with various ligands to the EGF receptor, such as EGF, TGF-alpha, HB-EGF, and amphiregulin, also decreased apoB secretion. Inhibition of apoB secretion by EGF was prevented by the mAb 528 or an EGF neutralizing antibody. In a dose- dependent manner, the neutralizing antibody to EGF prevented the decrease in secretion of apoB, triacylglycerol mass, and cell-surface binding of labeled EGF caused by IL-6. Similar to the effects of IL-6, EGF decreased the secretion of triacylglycerol mass and the synthesis and secretion on newly synthesized apoB. The results suggest that, in CaCo-2 cells, IL-6 causes the release of EGF or an EGF-like molecule. By binding to cell surface EGF receptors, the molecule then causes a decrease in triacylglycerol and apoB secretion.
This article has been cited by other articles:
![]() |
A. A. Jackson, G. Phillips, I. McClelland, and F. Jahoor Synthesis of hepatic secretory proteins in normal adults consuming a diet marginally adequate in protein Am J Physiol Gastrointest Liver Physiol, November 1, 2001; 281(5): G1179 - G1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tomiya, I. Ogata, M. Yamaoka, M. Yanase, Y. Inoue, and K. Fujiwara The Mitogenic Activity of Hepatocyte Growth Factor on Rat Hepatocytes Is Dependent upon Endogenous Transforming Growth Factor-{alpha} Am. J. Pathol., November 1, 2000; 157(5): 1693 - 1701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. E. Vreugdenhil, A. M. P. Snoek, J. W. M. Greve, and W. A. Buurman Lipopolysaccharide-Binding Protein Is Vectorially Secreted and Transported by Cultured Intestinal Epithelial Cells and Is Present in the Intestinal Mucus of Mice J. Immunol., October 15, 2000; 165(8): 4561 - 4566. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Gierens, M. Nauck, M. Roth, R. Schinker, C. Schurmann, H. Scharnagl, G. Neuhaus, H. Wieland, and W. Marz Interleukin-6 Stimulates LDL Receptor Gene Expression via Activation of Sterol-Responsive and Sp1 Binding Elements Arterioscler. Thromb. Vasc. Biol., July 1, 2000; 20(7): 1777 - 1783. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Murthy, S. N. Mathur, and F. J. Field Tumor Necrosis Factor-alpha and Interleukin-1beta Inhibit Apolipoprotein B Secretion in CaCo-2 Cells via the Epidermal Growth Factor Receptor Signaling Pathway J. Biol. Chem., March 24, 2000; 275(13): 9222 - 9229. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Darimont, N. Gradoux, and A. de Pover Epidermal growth factor regulates fatty acid uptake and metabolism in Caco-2 cells Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G606 - G612. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |